0

Drug Regulatory Affairs: Review

Introduction to regulatory affairs

Erschienen am 03.03.2019, 1. Auflage 2019
39,90 €
(inkl. MwSt.)

Lieferbar innerhalb 1 - 2 Wochen

In den Warenkorb
Bibliografische Daten
ISBN/EAN: 9786202057738
Sprache: Englisch
Umfang: 52 S.
Format (T/L/B): 0.4 x 22 x 15 cm
Einband: kartoniertes Buch

Beschreibung

Drug development to commercialization is highly regulated. Every drug before getting market approval must undergo rigorous scrutiny and clinical trials to ensure its safety, efficacy and quality. Regulatory department is crucial link between company, products and regulatory authorities. In todays competitive environment the reduction of the time taken to reach the market is vital to a products and hence the companys success. The proper conduct of its Regulatory Affairs activities is therefore of considerable economic significance for the company. The success of regulatory strategy is less dependent on the regulations than on how they are interpreted, applied, and communicated within companies and to outside constituents. Regulatory Affairs plays a crucial role in the pharmaceutical industry and is involved in all stages of drug development and also after drug approval and marketing. In this book provides basic information regarding Regulatory Affairs- its important in pharmaceutical industry, Responsibility of regulatory professions, list of various regulatory authorities and their regulations etc

Produktsicherheitsverordnung

Hersteller:
BoD - Books on Demand
[email protected]
In de Tarpen 42
DE 22848 Norderstedt

Autorenportrait

Mr. Vinod Vishnu Waghmare, M.Pharm (Pharmaceutics), from Shivaji University, Kolhapur. Currently he is working as Regulatory affairs -Manager in Galaxy Pharmaceuticals, Kenya.